Thrombocytopenia and management of anticoagulation in the patient with thrombosis and cancer
Cancer-associated thrombosis (CAT) presents a unique and multifaceted challenge in clinical practice, particularly in...
LATEST ARTICLES
The Combined Impact of Serum Albumin and Genetic Risk on VTE: Implications for Early Prevention
Venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most...
Heparin-Induced Thrombocytopenia: The Expanding Role of Factor Xa Inhibitors in Therapy
Heparin products, such as unfractionated heparin and low-molecular-weight heparin (LMWH), are commonly employed as...
An Overview of VTE Prevention and Management in Gynecological Cancer Care
As with cancers in general, gynecological cancers also exhibit a clear and increasingly significant association with...
Thromboprophylaxis in Portuguese Cancer Outpatients: Real-World Insights and Patient Characterization
Venous thromboembolism (VTE) affects up to 20% of cancer patients, presenting a four-to-seven-fold increased risk...
Prophylaxis of VTE in the colorectal cancer patient
Colorectal cancer (CRC) is the third most common cancer worldwide and the most prevalent tumor in Western countries,...